FREE Daily Stock Alerts From Stock-PR.com
Power3 Medical Products, Inc. (OTC:PWRM) a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases, announced recently that it delivered four poster presentations at the 2010 International Conference on Alzheimer's Disease in Honolulu, Hawaii. These presentations discussed NuroPro, Power3's diagnostic test, and focused on Power3's Alzheimer's disease blood serum biomarkers, test and clinical validation trials. Power3 has filed several patent applications for its NuroPro technology that are currently pending. Power3 also has a world-wide exclusive license from the Baylor College of Medicine in Houston, Texas. To date, Power3 has given 9 presentations on NuroPro at international scientific meetings in the United States, Europe and China, and has published 6 articles in peer-reviewed scientific journals on the subject. Power3 intends to publish these latest findings as well.
Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig's disease). Power3 applies proprietary methodologies to discover and identify protein biomarkers associated with diseases.
Eline Entertainment Group Inc. (OTCPK:EEGI) subsidiary Let The Good Times Roll, Inc. recently announced a joint venture with the Hard Rock Hotel and Casino. This new incentivized agreement with provides LTGTR riders with $25-$35 in gaming chips and a $5 food voucher when booked for the Hard Rock Casino. LTGTR, will experiment and plans to start running shuttles to the Hard Rock, charging $25-30 for round trip services. The deal is conditionally approved and subject to pending insurance verification. The company sees this as a simple administrative task, and to be resolved shortly.
LTGTR, which provides the premier "party on wheels" experience, intends to increase revenue streams through adding standard shuttle routes and joint ventures with popular venues such as this one. LTGTR has begun by creating Luxury Shuttles designed to travel from regionally isolated areas to populated hotspots. This includes a division of "Safety Shuttles" geared towards college students, intended to give "of-age" students the ability to enjoy nightlife without the hassle of designated drivers, parking fees, etc.
Force Protection Inc. (Nasdaq:FRPT) announced recently that it has signed a contract with the UK Ministry of Defence to supply an order of 200 Ocelots and an initial spares package for the Light Protected Patrol Vehicle (LPPV) program. The contract is valued at approximately £180 million (approximately US $280 million) with delivery of the vehicles scheduled to begin in the second half of 2011 and be completed by spring 2012.
Force Protection, Inc., together with its subsidiaries, engages in the design, manufacture, testing, delivery, and support of blast and ballistic protected vehicles. The company?s specialty vehicles protect their occupants from landmines, hostile fire, and improvised explosive devices (IEDs). Its vehicle platforms comprise The Buffalo, a mine protected clearance vehicle; and The Cougar, a family of medium-sized blast and ballistic-protected vehicles.
China Information Technology, Inc (Nasdaq:CNIT) recently announced its patented Medical Statistics Software has been adopted by five major hospitals in Guangxi Province.
China Information Technology, Inc. specializes in Geographic Information System (NYSE:GIS), digital public security, and hospital information systems in China. The company also engages in the sale of computer hardware and software, as well as in the provision of Certificate Authority, an application platform and e-Government solution technology. Its products and services include the First Responder Coordination Platform, a software program that integrates the contact numbers for general police.
Ariad Pharmaceuticals Inc. (Nasdaq:ARIA) recently announced that updated clinical data from a fully enrolled Phase 1 trial of its investigational, pan-BCR-ABL inhibitor, ponatinib, will be presented at the 52nd Annual Meeting of the American Society of Hematology being held in Orlando, Florida, December 4-7, 2010.
ARIAD Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer in the United States, Europe, and Japan.
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Stock-PR.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold Stock-PR.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://stock-pr.com/disclaimer).Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (OTCPK:CRWE) has received 1,000,000 shares 144 restricted stocks for IT department services from Power 3 Medical Products Inc. (OTC:PWRM). Crown Equity Holdings Inc. (OTCPK:CRWE) has received five thousand dollars and anticipates receiving another forty five thousand dollars in cash from a third party for (thirty) days of advertising for Eline Entertainment Group, Inc. (OTCPK:EEGI).
Sign Up For Free Stock Alerts At http://stock-pr.com/signup
________________________________________Be Sure To Visit stock-pr.ning.com
The views expressed in any article, reports, writings are not necessarily the views of Crown Equity Holdings Inc. its officers, directors, staff, contractors or employees. They do not represent the views or opinions of this site. Views expressed in articles are those of the author alone.